概括
两种常见的尿液药物查方法,即测试滴卡和EMIT,表现相似,但在检测特定物质方面不如LC-MS/MS准确. 对于积极的结果,建议确认LC-MS/MS.
科学领域:
- 临床化学 临床化学
- 毒理学 毒理学 毒理学
- 分析化学 分析化学
背景情况:
- 药物使用是全球日益严重的公共卫生问题.
- 在医学实验室进行准确的药物滥用测试至关重要.
- 药物查存在各种方法,需要进行比较研究.
研究的目的:
- 为了比较两种常见的尿液药物查方法的诊断性能:测试滴卡和EMIT (酶倍增免疫测试技术).
- 为了对这些方法与参考标准进行评估,液体染色学-并联质谱学 (LC-MS/MS).
主要方法:
- 分析了102名患者的尿样.
- 样品使用测试卡和EMIT进行了选.
- 分析了51个样本的子集,使用LC-MS/MS作为黄金标准.
主要成果:
- 所有患者的测试卡和EMIT结果都是兼容的.
- 敏感性和特异性因药物和方法而异,LC-MS/MS显示AMP,MDMA,OPI/MOP和THC的精度更高.
- 例如,AMP的测试卡灵敏度为70%,特异性为96%,而EMIT显示了76%的灵敏度和97%的特异性.
结论:
- 免疫化学方法 (测试卡和EMIT) 对几种药物具有相似的性能,但对某些物质的敏感度/特异性低于LC-MS/MS.
- 免疫化学查的阳性结果应使用LC-MS/MS等确定的方法来确认,以确保准确性.
相关概念视频
Drug Elimination by Renal Route: Tubular Reabsorption
3.4K
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
3.4K
Factors Affecting Renal Clearance: Renal Impairment
91
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
91
Renal Drug Excretion: Tubular Reabsorption
171
Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
171
One-Compartment Open Model: Urinary Excretion Data and Determination of k
174
The one-compartment open model leverages urinary excretion data to estimate renal clearance, which gauges the kidney's capacity to expel a drug. This method offers several benefits, including directly measuring drug elimination and assessing the kidney's contribution to overall drug clearance. However, this approach has limitations. It assumes sole renal excretion of the drug, which is not true for all drugs. Accurate urinary excretion and plasma drug concentration measurement can also...
174
Determination of Renal Drug Clearance: Graphical and Midpoint Methods
116
Renal clearance, a crucial parameter in pharmacokinetics, can be determined using two different methods: the graphical method and the midpoint method. These methods provide insights into the rate of drug excretion by the kidneys and aid in assessing renal function.
The graphical method involves plotting the rate of drug excretion in urine against the plasma drug concentration. By analyzing the graph, the clearance can be calculated and obtained. Drugs rapidly excreted by the kidneys exhibit a...
The graphical method involves plotting the rate of drug excretion in urine against the plasma drug concentration. By analyzing the graph, the clearance can be calculated and obtained. Drugs rapidly excreted by the kidneys exhibit a...
116
Drug Concentrations: Measurements
373
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
Plasma...
373


